382 related articles for article (PubMed ID: 16056392)
21. Autonomic neural regulation of immunity.
Czura CJ; Tracey KJ
J Intern Med; 2005 Feb; 257(2):156-66. PubMed ID: 15656874
[TBL] [Abstract][Full Text] [Related]
22. Vagal Modulation of the Inflammatory Response in Sepsis.
Wang DW; Yin YM; Yao YM
Int Rev Immunol; 2016 Sep; 35(5):415-433. PubMed ID: 27128144
[TBL] [Abstract][Full Text] [Related]
23. Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases.
Egleton RD; Brown KC; Dasgupta P
Pharmacol Ther; 2009 Feb; 121(2):205-23. PubMed ID: 19063919
[TBL] [Abstract][Full Text] [Related]
24. Role of cholinergic anti-inflammatory pathway in regulating host response and its interventional strategy for inflammatory diseases.
Wang DW; Zhou RB; Yao YM
Chin J Traumatol; 2009 Dec; 12(6):355-64. PubMed ID: 19930906
[TBL] [Abstract][Full Text] [Related]
25. Controlling inflammation: the cholinergic anti-inflammatory pathway.
Pavlov VA; Tracey KJ
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1037-40. PubMed ID: 17073745
[TBL] [Abstract][Full Text] [Related]
26. α7 nicotinic acetylcholine receptor (α7nAChR) expression in bone marrow-derived non-T cells is required for the inflammatory reflex.
Olofsson PS; Katz DA; Rosas-Ballina M; Levine YA; Ochani M; Valdés-Ferrer SI; Pavlov VA; Tracey KJ; Chavan SS
Mol Med; 2012 May; 18(1):539-43. PubMed ID: 22183893
[TBL] [Abstract][Full Text] [Related]
27. Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests.
Andreasen JT; Olsen GM; Wiborg O; Redrobe JP
J Psychopharmacol; 2009 Sep; 23(7):797-804. PubMed ID: 18583432
[TBL] [Abstract][Full Text] [Related]
28. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis.
Huston JM; Gallowitsch-Puerta M; Ochani M; Ochani K; Yuan R; Rosas-Ballina M; Ashok M; Goldstein RS; Chavan S; Pavlov VA; Metz CN; Yang H; Czura CJ; Wang H; Tracey KJ
Crit Care Med; 2007 Dec; 35(12):2762-8. PubMed ID: 17901837
[TBL] [Abstract][Full Text] [Related]
29. Vagus-brain communication in atherosclerosis-related inflammation: a neuroimmunomodulation perspective of CAD.
Gidron Y; Kupper N; Kwaijtaal M; Winter J; Denollet J
Atherosclerosis; 2007 Dec; 195(2):e1-9. PubMed ID: 17101139
[TBL] [Abstract][Full Text] [Related]
30. Facilitation of glutamate release by nicotine involves the activation of a Ca2+/calmodulin signaling pathway in rat prefrontal cortex nerve terminals.
Wang BW; Liao WN; Chang CT; Wang SJ
Synapse; 2006 Jun; 59(8):491-501. PubMed ID: 16565963
[TBL] [Abstract][Full Text] [Related]
31. Chronic nicotine stimulation modulates the immune response of mucosal T cells to Th1-dominant pattern via nAChR by upregulation of Th1-specific transcriptional factor.
Kikuchi H; Itoh J; Fukuda S
Neurosci Lett; 2008 Feb; 432(3):217-21. PubMed ID: 18248893
[TBL] [Abstract][Full Text] [Related]
32. The inflammatory reflex--introduction.
Andersson J
J Intern Med; 2005 Feb; 257(2):122-5. PubMed ID: 15656871
[TBL] [Abstract][Full Text] [Related]
33. Immunologic role of the cholinergic anti-inflammatory pathway and the nicotinic acetylcholine alpha 7 receptor.
Gallowitsch-Puerta M; Tracey KJ
Ann N Y Acad Sci; 2005 Dec; 1062():209-19. PubMed ID: 16461803
[TBL] [Abstract][Full Text] [Related]
34. Nicotinic acetylcholine receptor agonists may be a novel therapy for endometriosis.
Wu Y; Wang LP; Pan JQ
Med Hypotheses; 2011 Nov; 77(5):745-7. PubMed ID: 21835554
[TBL] [Abstract][Full Text] [Related]
35. Central nicotinic receptors: structure, function, ligands, and therapeutic potential.
Romanelli MN; Gratteri P; Guandalini L; Martini E; Bonaccini C; Gualtieri F
ChemMedChem; 2007 Jun; 2(6):746-67. PubMed ID: 17295372
[TBL] [Abstract][Full Text] [Related]
36. The vagus nerve and the inflammatory reflex: wandering on a new treatment paradigm for systemic inflammation and sepsis.
Huston JM
Surg Infect (Larchmt); 2012 Aug; 13(4):187-93. PubMed ID: 22913335
[TBL] [Abstract][Full Text] [Related]
37. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.
Olincy A; Harris JG; Johnson LL; Pender V; Kongs S; Allensworth D; Ellis J; Zerbe GO; Leonard S; Stevens KE; Stevens JO; Martin L; Adler LE; Soti F; Kem WR; Freedman R
Arch Gen Psychiatry; 2006 Jun; 63(6):630-8. PubMed ID: 16754836
[TBL] [Abstract][Full Text] [Related]
38. Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis.
Arias HR; Richards VE; Ng D; Ghafoori ME; Le V; Mousa SA
Int J Biochem Cell Biol; 2009 Jul; 41(7):1441-51. PubMed ID: 19401144
[TBL] [Abstract][Full Text] [Related]
39. alpha7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and Mesothelioma?
Paleari L; Cesario A; Fini M; Russo P
Drug Discov Today; 2009 Sep; 14(17-18):822-36. PubMed ID: 19616116
[TBL] [Abstract][Full Text] [Related]
40. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model.
Ghia JE; Blennerhassett P; Kumar-Ondiveeran H; Verdu EF; Collins SM
Gastroenterology; 2006 Oct; 131(4):1122-30. PubMed ID: 17030182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
